The uptake rates of Mitoxantrone by BCRP were examined in the presence of various pharmacological classes of ABC transporter inhibitors, such as antiviral ( i. e. Erythromycin, Foscarnet ), antibiotic ( i. e. Ciprofloxacin, Febendazole, Novobiocin, Quercitin ), calcium channel blockers ( i. e. Verapamil, Diltiazem, Nifedipine, Qunidine ), anticancer ( i. e. Mitroxantrone, Acyclovir, FTC, Phenethyl ITC, Raloxifene, Rodamin 123, Saquinavir, Tamoxifene ), antifungal agents ( i. e. Ketoconazole ), hormones ( i. e ., Estradiol) and immunosuppressant ( Cyclosporin) [ 16, 23 ].	"Mitoxantrone	20	32	Chemical/Drug"	"BCRP	36	40	Gene/Protein"	"ABC transporter	109	124	Gene/Protein"	"Erythromycin	163	175	Chemical/Drug"	"Foscarnet	177	186	Chemical/Drug"	"Ciprofloxacin	209	222	Chemical/Drug"	"Febendazole	224	235	Chemical/Drug"	"Novobiocin	237	247	Chemical/Drug"	"Quercitin	249	258	Chemical/Drug"	"calcium channel	262	277	Gene/Protein"	"Verapamil	295	304	Chemical/Drug"	"Diltiazem	306	315	Chemical/Drug"	"Nifedipine	317	327	Chemical/Drug"	"Qunidine	329	337	Chemical/Drug"	"Mitroxantrone	360	373	Chemical/Drug"	"Acyclovir	375	384	Chemical/Drug"	"Raloxifene	406	416	Chemical/Drug"	"Rodamin 123	418	429	Chemical/Drug"	"Saquinavir	431	441	Chemical/Drug"	"Tamoxifene	443	453	Chemical/Drug"	"Ketoconazole	483	495	Chemical/Drug"	"hormones	499	507	Gene/Protein"	"Estradiol	518	527	Chemical/Drug"	"Cyclosporin	553	564	Chemical/Drug"	"[{""token"": ""Mitoxantrone"", ""start_span"": 20, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""BCRP"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""ABC transporter"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""Erythromycin"", ""start_span"": 163, ""end_span"": 175, ""type"": ""Chemical/Drug""}, {""token"": ""Foscarnet"", ""start_span"": 177, ""end_span"": 186, ""type"": ""Chemical/Drug""}, {""token"": ""Ciprofloxacin"", ""start_span"": 209, ""end_span"": 222, ""type"": ""Chemical/Drug""}, {""token"": ""Febendazole"", ""start_span"": 224, ""end_span"": 235, ""type"": ""Chemical/Drug""}, {""token"": ""Novobiocin"", ""start_span"": 237, ""end_span"": 247, ""type"": ""Chemical/Drug""}, {""token"": ""Quercitin"", ""start_span"": 249, ""end_span"": 258, ""type"": ""Chemical/Drug""}, {""token"": ""calcium channel"", ""start_span"": 262, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""Verapamil"", ""start_span"": 295, ""end_span"": 304, ""type"": ""Chemical/Drug""}, {""token"": ""Diltiazem"", ""start_span"": 306, ""end_span"": 315, ""type"": ""Chemical/Drug""}, {""token"": ""Nifedipine"", ""start_span"": 317, ""end_span"": 327, ""type"": ""Chemical/Drug""}, {""token"": ""Qunidine"", ""start_span"": 329, ""end_span"": 337, ""type"": ""Chemical/Drug""}, {""token"": ""Mitroxantrone"", ""start_span"": 360, ""end_span"": 373, ""type"": ""Chemical/Drug""}, {""token"": ""Acyclovir"", ""start_span"": 375, ""end_span"": 384, ""type"": ""Chemical/Drug""}, {""token"": ""Raloxifene"", ""start_span"": 406, ""end_span"": 416, ""type"": ""Chemical/Drug""}, {""token"": ""Rodamin 123"", ""start_span"": 418, ""end_span"": 429, ""type"": ""Chemical/Drug""}, {""token"": ""Saquinavir"", ""start_span"": 431, ""end_span"": 441, ""type"": ""Chemical/Drug""}, {""token"": ""Tamoxifene"", ""start_span"": 443, ""end_span"": 453, ""type"": ""Chemical/Drug""}, {""token"": ""Ketoconazole"", ""start_span"": 483, ""end_span"": 495, ""type"": ""Chemical/Drug""}, {""token"": ""hormones"", ""start_span"": 499, ""end_span"": 507, ""type"": ""Gene/Protein""}, {""token"": ""Estradiol"", ""start_span"": 518, ""end_span"": 527, ""type"": ""Chemical/Drug""}, {""token"": ""Cyclosporin"", ""start_span"": 553, ""end_span"": 564, ""type"": ""Chemical/Drug""}]"
Percent variation of MedFI of CD14, CD16 and CD163 compared to CTR ( IL - 10 alone ). Error bars represent + SD, n = 5 * p < 0. 05, ** p < 0. 005 ( Kruskal - Wallis analysis followed by Dunn ’ s post hoc test ). MB231, MDA - MB231 CMFig. 3Cytokine secretion profile after 24 h of lipopolysaccharide ( LPS )- stimulation. a - c CD14 + cells differentiated for 5 days with or without 50% breast cancer cell line conditioned media ( CM) ( d - f) in the presence of IL - 4 ( g - i) in the presence of IL - 10. a - i All results are the mean of three experimental replicates and two biological replicates. j Representative matrix metalloproteinase ( MMP )- 9 zymography gel ( k) relative MMP - 9 activity, expressed as digested band optical density normalized to equivalent background area optical density. Error bars represent + SD, n = 3, * p < 0. 05, ** p < 0. 005, *** p < 0. 0005 ( Kruskal - Wallis analysis followed by Dunn ’ s post hoc test ). MB231, MDA - MB231 CM; NT, non - treatedFig. 4Flow cytometry analysis of CD14 + cells differentiated for 5 days in the presence of IL - 4 with or without 50% conditioned media ( CM ). a CD14loCD16lo and CD14hiCD16hi subpopulation distribution. b, d, f, h, j Overall percent variation of CD14, CD16, CD163, CD200R and CD86 median fluorescence intensity ( MedFI ), compared with control ( CTR) ( IL - 4 alone) ( c, e, g, i, k) CD14 CD16, CD163, CD200R and CD86 MedFI percent variation in the subpopulations CD14loCD16lo and CD14hiCD16hi. Error bars represent + SD, n = 5, * p < 0. 05, ** p < 0. 005, *** p < 0. 0005 ( Kruskal - Wallis analysis followed by Dunn ’ s post hoc test ). MB231, MDA - MB231 CM	"CD14	30	34	Gene/Protein"	"CD16	36	40	Gene/Protein"	"CD163	45	50	Gene/Protein"	"IL - 10	69	76	Gene/Protein"	"CD14	327	331	Gene/Protein"	"breast cancer	386	399	Disease/Disorder"	"IL - 4	462	468	Gene/Protein"	"IL - 10	497	504	Gene/Protein"	"matrix metalloproteinase	618	642	Gene/Protein"	"( MMP )- 9	643	653	Gene/Protein"	"MMP - 9	683	690	Gene/Protein"	"CD14	1019	1023	Gene/Protein"	"IL - 4	1077	1083	Gene/Protein"	"CD14	1132	1136	Gene/Protein"	"CD16	1138	1142	Gene/Protein"	"CD163	1245	1250	Gene/Protein"	"CD200R	1252	1258	Gene/Protein"	"CD86	1263	1267	Gene/Protein"	"IL - 4	1340	1346	Gene/Protein"	"CD14	1371	1375	Gene/Protein"	"CD16	1376	1380	Gene/Protein"	"CD163	1382	1387	Gene/Protein"	"CD200R	1389	1395	Gene/Protein"	"CD86	1400	1404	Gene/Protein"	"[{""token"": ""CD14"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 327, ""end_span"": 331, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 386, ""end_span"": 399, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 4"", ""start_span"": 462, ""end_span"": 468, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 497, ""end_span"": 504, ""type"": ""Gene/Protein""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 618, ""end_span"": 642, ""type"": ""Gene/Protein""}, {""token"": ""( MMP )- 9"", ""start_span"": 643, ""end_span"": 653, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 683, ""end_span"": 690, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 1019, ""end_span"": 1023, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 1077, ""end_span"": 1083, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 1132, ""end_span"": 1136, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 1138, ""end_span"": 1142, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 1245, ""end_span"": 1250, ""type"": ""Gene/Protein""}, {""token"": ""CD200R"", ""start_span"": 1252, ""end_span"": 1258, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 1263, ""end_span"": 1267, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 1340, ""end_span"": 1346, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 1371, ""end_span"": 1375, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 1376, ""end_span"": 1380, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 1382, ""end_span"": 1387, ""type"": ""Gene/Protein""}, {""token"": ""CD200R"", ""start_span"": 1389, ""end_span"": 1395, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 1400, ""end_span"": 1404, ""type"": ""Gene/Protein""}]"
DC samples were analyzed by SDS - PAGE and immunoblotting using rabbit - anti - human SOCS1 ( Cell Signaling, 3950, 1: 750 ), rabbit - anti - human SOCS2 ( Cell Signaling, 2779, 1: 500 ), goat - anti - rabbit - HRP ( Dako, P0448 1: 2000 ), mouse - anti - human GAPDH ( 9484 Abcam, UK, 1: 1000 ), rabbit - anti - mouse - HRP ( P0161, Dako, P0161, 1: 2000 ), rabbit - anti - human SHP1 ( GeneTex, 102865, 1: 500) rabbit - anti - human SHP2 ( Santa Cruz, C - 18, 1: 250) and goat - anti - human Actin ( Santa Cruz, I - 19, 1: 2000 ).	"rabbit	64	70	Organism/Species"	"human	80	85	Organism/Species"	"SOCS1	86	91	Gene/Protein"	"rabbit	126	132	Organism/Species"	"human	142	147	Organism/Species"	"SOCS2	148	153	Gene/Protein"	"goat	188	192	Organism/Species"	"rabbit	202	208	Organism/Species"	"HRP	211	214	Gene/Protein"	"mouse	240	245	Organism/Species"	"human	255	260	Organism/Species"	"GAPDH	261	266	Gene/Protein"	"rabbit	296	302	Organism/Species"	"mouse	312	317	Organism/Species"	"HRP	320	323	Gene/Protein"	"rabbit	357	363	Organism/Species"	"human	373	378	Organism/Species"	"SHP1	379	383	Gene/Protein"	"rabbit	411	417	Organism/Species"	"human	427	432	Organism/Species"	"SHP2	433	437	Gene/Protein"	"goat	472	476	Organism/Species"	"human	486	491	Organism/Species"	"Actin	492	497	Gene/Protein"	"[{""token"": ""rabbit"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""SOCS1"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""SOCS2"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 202, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""HRP"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 240, ""end_span"": 245, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 255, ""end_span"": 260, ""type"": ""Organism/Species""}, {""token"": ""GAPDH"", ""start_span"": 261, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 296, ""end_span"": 302, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 312, ""end_span"": 317, ""type"": ""Organism/Species""}, {""token"": ""HRP"", ""start_span"": 320, ""end_span"": 323, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 357, ""end_span"": 363, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 373, ""end_span"": 378, ""type"": ""Organism/Species""}, {""token"": ""SHP1"", ""start_span"": 379, ""end_span"": 383, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 411, ""end_span"": 417, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 427, ""end_span"": 432, ""type"": ""Organism/Species""}, {""token"": ""SHP2"", ""start_span"": 433, ""end_span"": 437, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 472, ""end_span"": 476, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 486, ""end_span"": 491, ""type"": ""Organism/Species""}, {""token"": ""Actin"", ""start_span"": 492, ""end_span"": 497, ""type"": ""Gene/Protein""}]"
In particular, the violet module ( lowest bar) shows the most upregulated genes in Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/- mice ( i. e ., Exo1, P = 0. 031; Pttg1, P = 0. 001 ); in the gray module are listed the genes downregulated in Rad54 -/-/ Ptc1 +/- and Parp - 1 -/-/ Ptc1 +/- mutants that are upregulated in Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/- mice, of which Xpa was statistically significant ( P = 0. 033 ); instead, in the red module, the synergistic effects of combined Rad54 and Parp - 1 mutations lead to downregulation of several genes ( i. e ., Atm, P = 0. 031; Atr, P = 0. 008; Atrx, P = 0. 006; Parp - 1, P = 0. 001; Prkdc, P = 0. 029; Rad50, P = 0. 028; Wrn, P = 0. 016) ( Figure 5A and Table S1 ).	"Rad54	83	88	Gene/Protein"	"Parp - 1	94	102	Gene/Protein"	"Ptc1	108	112	Gene/Protein"	"mice	117	121	Organism/Species"	"Exo1	132	136	Gene/Protein"	"Pttg1	150	155	Gene/Protein"	"Rad54	228	233	Gene/Protein"	"Ptc1	239	243	Gene/Protein"	"Parp - 1	252	260	Gene/Protein"	"Ptc1	266	270	Gene/Protein"	"Rad54	307	312	Gene/Protein"	"Parp - 1	318	326	Gene/Protein"	"Ptc1	332	336	Gene/Protein"	"mice	341	345	Organism/Species"	"Xpa	356	359	Gene/Protein"	"Rad54	470	475	Gene/Protein"	"Parp - 1	480	488	Gene/Protein"	"Atm	549	552	Gene/Protein"	"Atr	566	569	Gene/Protein"	"Atrx	583	587	Gene/Protein"	"Parp - 1	601	609	Gene/Protein"	"Prkdc	623	628	Gene/Protein"	"Rad50	642	647	Gene/Protein"	"Wrn	661	664	Gene/Protein"	"[{""token"": ""Rad54"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""Exo1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Pttg1"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 228, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 252, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 266, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 307, ""end_span"": 312, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 318, ""end_span"": 326, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 332, ""end_span"": 336, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 341, ""end_span"": 345, ""type"": ""Organism/Species""}, {""token"": ""Xpa"", ""start_span"": 356, ""end_span"": 359, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 470, ""end_span"": 475, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 480, ""end_span"": 488, ""type"": ""Gene/Protein""}, {""token"": ""Atm"", ""start_span"": 549, ""end_span"": 552, ""type"": ""Gene/Protein""}, {""token"": ""Atr"", ""start_span"": 566, ""end_span"": 569, ""type"": ""Gene/Protein""}, {""token"": ""Atrx"", ""start_span"": 583, ""end_span"": 587, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 601, ""end_span"": 609, ""type"": ""Gene/Protein""}, {""token"": ""Prkdc"", ""start_span"": 623, ""end_span"": 628, ""type"": ""Gene/Protein""}, {""token"": ""Rad50"", ""start_span"": 642, ""end_span"": 647, ""type"": ""Gene/Protein""}, {""token"": ""Wrn"", ""start_span"": 661, ""end_span"": 664, ""type"": ""Gene/Protein""}]"
